Paul R. Fortin
Chercheur universitaire clinicien
Axe Maladies infectieuses et immunitaires
Maladies auto-immunes
Publications
Voir tout-
article Arnaud L, Monticielo OA, Piga M, Costedoat-Chalumeau N, Touma Z, Ruiz-Irastorza G, Bae SC, Bernatsky S, Bonfa E, Bottazzi F, Cervera R, Chehab G, Clarke AE, Dall'era M, Duarte-Garcia A, Espinosa G, Fortin PR, Fredi M, Gómez-Puerta JA, Izuka S, Jönsen A, Khmelinskii N, Legge A, Meisalu S, Moroni L, Orsolini G, Padjen I, Petri M, Pons-Estel G, Ramirez GA, Ramsey-Goldman R, Sciascia S, Tincani A, Triggiani M, Ugarte-Gil MF, Vinet E, Vital EM, Mosca M, Tani C and
ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2)
Lancet Rheumatol 2026.
-
article McGuire E, Andersen NJ, Lacaille D, Savard J, Fortin PR, Rahme E, Da Costa D
Insomnia Treatment Preferences and Barriers of Individuals With Arthritis
ACR Open Rheumatol 8 (8), 2026.
-
article Andersen NJ, McGuire E, Lacaille D, Savard J, Rahme E, Fortin PR, Da Costa D
Cannabis Use in Arthritis: Impact on Health-Related Quality of Life
Med Cannabis Cannabinoids 9 (1), 2026.
Projets
- Booster dose of mRNA SARS-CoV-2 vaccine vs non mRNA vaccine for people living with systemic autoimmune rhumatic diseases without adequate humoral response post standard mRNA vaccination, du 2021-12-01 au 2027-03-31
- Role of phosphatidylserine-specific phospholipase A1 (PLA1A) in the pathogenesis of rheumatic diseases, du 2023-01-01 au 2026-12-31
- Role of megakaryocytes in Systemic Lupus Erythematosus, du 2023-04-01 au 2028-03-31
- Risk stratification and personalized therapy in lupus pregnancies, du 2022-10-01 au 2027-09-30
- The contribution of platelets and B-cells to neurolupus pathophysiology, du 2025-10-01 au 2030-09-30
- Impact of vascular injury derived exosomes on Lupus nephritis, du 2022-04-01 au 2027-03-31
- Canada research chair in Innovate Systemic Autoimmune Rheumatic Disease, du 2019-07-01 au 2026-06-30
- Platelets and neutrophils: the two culprits mediating pain in inflammatory arthritis, du 2020-04-01 au 2025-03-31
- FcgRI as a potential therapeutic target in inflammatory arthritis, du 2022-01-01 au 2025-12-31
- Mitochondrial mArkers To Characterize Heterogeneity in SLE (MATCH-SLE) (Planning grant), du 2024-12-01 au 2025-02-28
- Mental Health in Individuals with Autoimmune Rheumatic Diseases During the Transition to Parenthood: A Mixed Methods Study to Identify Associated Factors and Support Needs, du 2023-04-01 au 2025-09-30
- Pilot Implementation of the Purple Butterfly: Transforming Communication and Self-Management in Lupus Care, du 2025-09-23 au 2026-03-31